These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35026538)

  • 41. JAK/STAT inhibition augments soleus muscle function in a rat model of critical illness myopathy via regulation of complement C3/3R.
    Addinsall AB; Cacciani N; Akkad H; Salah H; Tchkonia T; Kirkland JL; Larsson L
    J Physiol; 2021 Jun; 599(11):2869-2886. PubMed ID: 33745126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study.
    Hermans G; Schrooten M; Van Damme P; Berends N; Bouckaert B; De Vooght W; Robberecht W; Van den Berghe G
    Crit Care; 2009; 13(1):R5. PubMed ID: 19166623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis.
    Latronico N; Bolton CF
    Lancet Neurol; 2011 Oct; 10(10):931-41. PubMed ID: 21939902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vamorolone treatment improves skeletal muscle outcome in a critical illness myopathy rat model.
    Akkad H; Cacciani N; Llano-Diez M; Corpeno Kalamgi R; Tchkonia T; Kirkland JL; Larsson L
    Acta Physiol (Oxf); 2019 Feb; 225(2):e13172. PubMed ID: 30120816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term neuromuscular sequelae of critical illness.
    Semmler A; Okulla T; Kaiser M; Seifert B; Heneka MT
    J Neurol; 2013 Jan; 260(1):151-7. PubMed ID: 22820684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impaired Ca(2+) release contributes to muscle weakness in a rat model of critical illness myopathy.
    Llano-Diez M; Cheng AJ; Jonsson W; Ivarsson N; Westerblad H; Sun V; Cacciani N; Larsson L; Bruton J
    Crit Care; 2016 Aug; 20(1):254. PubMed ID: 27510990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Understanding critical illness myopathy: approaching the pathomechanism.
    Friedrich O; Fink RH; Hund E
    J Nutr; 2005 Jul; 135(7):1813S-1817S. PubMed ID: 15987871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Critical illness myopathy as a consequence of Covid-19 infection.
    Tankisi H; Tankisi A; Harbo T; Markvardsen LK; Andersen H; Pedersen TH
    Clin Neurophysiol; 2020 Aug; 131(8):1931-1932. PubMed ID: 32619798
    [No Abstract]   [Full Text] [Related]  

  • 49. Critical Illness Neuropathy.
    Tankisi H; de Carvalho M; Z'Graggen WJ
    J Clin Neurophysiol; 2020 May; 37(3):205-207. PubMed ID: 32358246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study.
    Weber-Carstens S; Deja M; Koch S; Spranger J; Bubser F; Wernecke KD; Spies CD; Spuler S; Keh D
    Crit Care; 2010; 14(3):R119. PubMed ID: 20565863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuromuscular manifestations of critical illness.
    Bolton CF
    Muscle Nerve; 2005 Aug; 32(2):140-63. PubMed ID: 15825186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective clinical study on the mechanisms underlying critical illness myopathy-A time-course approach.
    Cacciani N; Skärlén Å; Wen Y; Zhang X; Addinsall AB; Llano-Diez M; Li M; Gransberg L; Hedström Y; Bellander BM; Nelson D; Bergquist J; Larsson L
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2669-2682. PubMed ID: 36222215
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electrodiagnostic studies in the intensive care unit: A comparison study 2 decades later.
    Ojha A; Zivkovic SA; Lacomis D
    Muscle Nerve; 2018 May; 57(5):772-776. PubMed ID: 29053882
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inflammation-induced acute phase response in skeletal muscle and critical illness myopathy.
    Langhans C; Weber-Carstens S; Schmidt F; Hamati J; Kny M; Zhu X; Wollersheim T; Koch S; Krebs M; Schulz H; Lodka D; Saar K; Labeit S; Spies C; Hubner N; Spranger J; Spuler S; Boschmann M; Dittmar G; Butler-Browne G; Mouly V; Fielitz J
    PLoS One; 2014; 9(3):e92048. PubMed ID: 24651840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuromuscular disorders in critically ill patients: review and update.
    Lacomis D
    J Clin Neuromuscul Dis; 2011 Jun; 12(4):197-218. PubMed ID: 22361518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Critical illness myopathy after COVID-19.
    Bagnato S; Boccagni C; Marino G; Prestandrea C; D'Agostino T; Rubino F
    Int J Infect Dis; 2020 Oct; 99():276-278. PubMed ID: 32763444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Signs of critical illness polyneuropathy and myopathy can be seen early in the ICU course.
    Ahlbeck K; Fredriksson K; Rooyackers O; Måbäck G; Remahl S; Ansved T; Eriksson L; Radell P
    Acta Anaesthesiol Scand; 2009 Jul; 53(6):717-23. PubMed ID: 19388901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validation of the peroneal nerve test to diagnose critical illness polyneuropathy and myopathy in the intensive care unit: the multicentre Italian CRIMYNE-2 diagnostic accuracy study.
    Latronico N; Nattino G; Guarneri B; Fagoni N; Amantini A; Bertolini G;
    F1000Res; 2014; 3():127. PubMed ID: 25309729
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Critical illness polyneuropathy and critical illness myopathy].
    Grimm A; Günther A; Witte OW; Axer H
    Med Klin Intensivmed Notfmed; 2012 Nov; 107(8):649-58; quiz 659. PubMed ID: 23104463
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Critical illness myopathy precedes hyperglycaemia and high glucose variability.
    Mörgeli R; Wollersheim T; Engelhardt LJ; Grunow JJ; Lachmann G; Carbon NM; Koch S; Spies C; Weber-Carstens S
    J Crit Care; 2021 Jun; 63():32-39. PubMed ID: 33592497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.